Patrick Vallance

Patrick Vallance is a renowned British pharmacologist and scientist who has made significant contributions to the field of pharmacology and medicine. He is currently the Chief Scientific Adviser to the UK Government, providing scientific advice to the Prime Minister and other senior government officials, including Boris Johnson and Rishi Sunak. Vallance has worked with various organizations, including University College London, GlaxoSmithKline, and the Royal Society, and has collaborated with prominent scientists such as David Cox and Michael Levitt. His work has been recognized by the Royal Society of Chemistry and the Academy of Medical Sciences.

● Early Life and Education

Patrick Vallance was born on March 17, 1960, in Essex, England, and grew up in a family of scientists, including his father, who was a chemistry teacher at Haberdashers' Aske's Boys' School. Vallance was educated at Trinity College, Cambridge, where he studied natural sciences and biochemistry, and later earned his PhD in pharmacology from the University of London. During his time at Cambridge University, he was influenced by prominent scientists such as James Watson and Francis Crick, who discovered the structure of DNA. Vallance's early research focused on the pharmacology of cardiovascular disease, and he worked with researchers at the Wellcome Trust and the British Heart Foundation.

● Career

Vallance began his career in the pharmaceutical industry, working as a researcher at Beecham Pharmaceuticals and later at GlaxoSmithKline, where he held various positions, including Head of Drug Discovery. During his time at GlaxoSmithKline, he worked on the development of several medicines, including antibiotics and vaccines, and collaborated with researchers at the World Health Organization and the National Institutes of Health. Vallance has also worked with various academic institutions, including University College London and the University of Oxford, and has held visiting professorships at the University of Cambridge and the Imperial College London. He has also served on the boards of several organizations, including the Royal Society and the Academy of Medical Sciences, and has worked with prominent scientists such as Stephen Hawking and Tim Hunt.

● Chief Scientific Adviser

In 2018, Vallance was appointed as the Chief Scientific Adviser to the UK Government, succeeding Mark Walport. As Chief Scientific Adviser, Vallance provides scientific advice to the Prime Minister and other senior government officials, including Boris Johnson and Rishi Sunak, on a range of issues, including climate change, public health, and innovation. He has worked closely with other government officials, including Chris Whitty and Jonathan Van-Tam, to provide scientific advice on issues such as the COVID-19 pandemic and the European Union's Horizon 2020 program. Vallance has also represented the UK Government at international meetings, including the G7 and the G20, and has worked with international organizations such as the World Health Organization and the European Commission.

● Research and Publications

Vallance has published numerous research papers in top scientific journals, including Nature, Science, and the New England Journal of Medicine. His research has focused on the pharmacology of cardiovascular disease and the development of new medicines. Vallance has also worked on the development of new vaccines and antibiotics, and has collaborated with researchers at the Wellcome Trust and the Bill and Melinda Gates Foundation. He has also written articles for popular science publications, including The Guardian and The Times, and has given lectures at institutions such as the Royal Institution and the Chatham House. Vallance's work has been recognized by the Royal Society of Chemistry and the Academy of Medical Sciences, and he has received awards from the British Pharmacological Society and the American Heart Association.

● Awards and Honours

Vallance has received numerous awards and honors for his contributions to science and medicine, including a knighthood from the Queen in 2019 for his services to science and public health. He is a Fellow of the Royal Society and a Fellow of the Academy of Medical Sciences, and has received awards from the British Pharmacological Society and the American Heart Association. Vallance has also been recognized by the European Commission for his contributions to European research and innovation, and has received the GlaxoSmithKline Research Award for his work on the development of new medicines. He has also been awarded honorary degrees from institutions such as the University of Cambridge and the University of Oxford, and has been recognized by the Royal Society of Chemistry for his contributions to chemistry and pharmacology.